Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06425848 · ClinicalTrials.gov registry record
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
A clinical trial of Heart Failure, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 12
- Study locations
NCT06425848 is a study of Heart Failure that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 2,000 participants, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target. The trial reports 12 study locations across 10 states.
The verdict
NCT06425848, a study of Heart Failure, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.
Conditions Studied
Interventions
- DEVICE Observational
Study Locations (12)
Minnesota
- Fairview Health - Maplewood
- Minneapolis Heart Institute Foundation/ Allina Health - Minneapolis
Texas
- Austin Heart - Austin
- Houston Methodist DeBakey Heart and Vascular Center - Houston
California
- Scripps Health - La Jolla
Indiana
- Indiana University - Bloomington
Kansas
- University of Kansas Medical Center - Kansas City
Missouri
- Saint Luke's Health System - Kansas City
North Carolina
- University of North Carolina/ Rex Hospital, Inc. - Raleigh
Oregon
- Providence Heart Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2022-10-21 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06425848
The ClinicalTrials.gov registry entry for NCT06425848 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT06425848 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Minnesota, Texas, California.
Frequently Asked Questions
What is clinical trial NCT06425848 about?
NCT06425848 is a clinical study titled "HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry". The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulator...
What is the current status of trial NCT06425848?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2022-10-21. Estimated completion is 2030-12-31.
What conditions does trial NCT06425848 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT06425848?
The interventions under investigation include: Observational (DEVICE).
Who is sponsoring clinical trial NCT06425848?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06425848 being conducted?
This trial has 12 study locations across California, Indiana, Kansas, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.